The drug Caplyta, owned by Intra-Cellular Therapies, is being used to treat bipolar disorder and schizophrenia. In 2024, it brought in more than $481 million in sales. 

The findings are concerning, especially considering the amount of orthopedic cases residents are involved in during call shifts, researchers caution.

Although some form of neural superiority may not be the driving factor behind an elite athlete’s talent, new evidence shows these individuals have unique structure and connectivity patterns.

Medtronic entered into an exclusive U.S. distribution agreement with Contego Medical for carotid and peripheral vascular disease revascularization products. The agreement includes an option to acquire the full company at a later date. 

Philips is recalling the software associated with its Mobile Cardiac Outpatient Telemetry devices after certain high-risk ECG events were never routed to trained cardiology technicians as intended. The issue, which lasted for two years, has been linked to more than 100 injuries. 

Heart Rhythm Society President Kenneth A. Ellenbogen, MD, detailed a new advocacy group focused on improving EP reimbursements, patient care and access. “If you’re not at the table, you’re on the menu," he said.

The findings are derived from a small survey of radiology department chairs, published in the Journal of the American College of Radiology. 

“As physicians who care deeply about the health and safety of our patients and communities, we are appalled by Donald Trump's reckless decision to appoint Robert F. Kennedy Jr.," over 19,000 docs wrote. 

LMI is the maker of Neuraceq, a globally approved F-18 PET imaging agent used to detect beta-amyloid plaques in patients evaluated for Alzheimer’s

Inglewood, California-based biotechnology company ImaginAb is the seller, unloading a pipeline of drug candidates, technology platform and research facility.